» Articles » PMID: 36255061

Prevalence and Risk of Diabetic Complications in Young-onset Versus Late-onset Type 2 Diabetes Mellitus

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2022 Oct 18
PMID 36255061
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To compare the prevalence and risk of diabetic complications between people with young-onset and late-onset type 2 diabetes mellitus (T2DM).

Methods: In this observational study, 10,447 people with T2DM had at least one study of diabetic complications: retinopathy, neuropathy, chronic kidney disease (CKD), carotid artery plaque. We use odds ratios to compare complications between young-onset T2DM (YOD) and late-onset T2DM (LOD).

Results: We compare 1,791 people with YOD (diagnosed < 40 years) and 8,656 with LOD (diagnosed ≥ 40 years). The YOD had a higher prevalence of these complications than the LOD (p < 0.011) after adjustment for confounding factors. Further adjustment for diabetes duration greatly attenuated the odds ratios however, neuropathy remained significantly more frequent in people with YOD (adjusted odds ratio: 1.39, 95% confidence interval: 1.13-1.71, p = 002). In cluster analysis on the 2,126 study participants who were diagnosed with T2DM within the previous two years, 47% of the YOD group were in the severe insulin-deficient diabetes cluster in comparison to 23% LOD; 28% and 44% respectively were in the mild age-related diabetes.

Conclusion: People with YOD had a higher prevalence of complications than those with LOD, but this was mostly attributed to a longer duration of diabetes. However, the prevalence of neuropathy remained significantly higher even after adjusting for factors including the duration of diabetes.

Citing Articles

Validation of a Deep Learning Model for Diabetic Retinopathy on Patients with Young-Onset Diabetes.

Tan-Torres 3rd A, Praveen P, Jeji D, Brant A, Yin X, Yang L Ophthalmol Ther. 2025; .

PMID: 40087218 DOI: 10.1007/s40123-025-01116-z.


Correlation Between Triglyceride-Glucose Index and Microvascular Complications in Patients With Early- Onset of Type 2 Diabetes Mellitus.

Ran L, Han Y, Zhaohu H, Hailin S Endocrinol Diabetes Metab. 2025; 8(2):e70027.

PMID: 39946246 PMC: 11824366. DOI: 10.1002/edm2.70027.


Association between age at diagnosis of diabetes and ocular disease: Insights from a recent article.

Liu S, Wang D, Tang C World J Diabetes. 2025; 16(1):94846.

PMID: 39817215 PMC: 11718463. DOI: 10.4239/wjd.v16.i1.94846.


Myeloid-Derived Suppressor Cells (MDSCs) and Obesity-Induced Inflammation in Type 2 Diabetes.

Ghemis L, Goriuc A, Minea B, Botnariu G, Martu M, Entuc M Diagnostics (Basel). 2024; 14(21).

PMID: 39518420 PMC: 11544947. DOI: 10.3390/diagnostics14212453.


The comorbidity burden of type 2 diabetes mellitus (T2DM): sex differences and associated factors among 830 cases in North-Eastern Morocco.

Kenfaoui I, Bouchefra S, Daouchi S, Benzakour A, Ouhssine M Diabetol Int. 2024; 15(4):814-827.

PMID: 39469545 PMC: 11513066. DOI: 10.1007/s13340-024-00750-5.